Showing results (511-520 of 794) with videos related to
Sort By:
Pageof 80
JAMA|July 10, 1996
Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USAC C Carpenter, M A Fischl, S M Hammer, et al.JAMA|September 29, 1999
Reduced antiretroviral drug susceptibility among patients with primary HIV infectionS J Little, E S Daar, R T D'Aquila, et al.Journal of Virology|February 14, 2004
Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infectionAndrew J Leigh Brown, Simon D W Frost, Benjamin Good, et al.JAMA|July 24, 2012
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panelMelanie A Thompson, Judith A Aberg, Jennifer F Hoy, et al.The Journal of Infectious Diseases|January 7, 1998
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapyI C Marschner, A C Collier, R W Coombs, et al.The Journal of Infectious Diseases|October 1, 1996
Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working GroupsR W Coombs, S L Welles, C Hooper, et al.Science (New York, N.Y.)|July 26, 2008
Whither or wither microbicides?Robert M Grant, Dean Hamer, Thomas Hope, et al.Brain : a Journal of Neurology|June 1, 2006
Genetic attributes of cerebrospinal fluid-derived HIV-1 envSatish K Pillai, Sergei L Kosakovsky Pond, Yang Liu, et al.Scientific Reports|February 5, 2021
Adaptor Template Oligo-Mediated Sequencing (ATOM-Seq) is a new ultra-sensitive UMI-based NGS library preparation technology for use with cfDNA and cfRNAThomas L Dunwell, Simon C Dailey, Anine L Ottestad, et al.JAMA|June 25, 1997
Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panelC C Carpenter, M A Fischl, S M Hammer, et al.Pageof 80